65 related articles for article (PubMed ID: 10994569)
1. [Quality of life and symptomatology in benign prostate hyperplasia in active Spanish population].
Gómez Acebo A; Rodríguez Vallejo JM; Rodríguez Mora VI; García Alcázar I
Med Clin (Barc); 2000; 114 Suppl 3():81-9. PubMed ID: 10994569
[TBL] [Abstract][Full Text] [Related]
2. [Quality of life assessment of the male with benign prostate hypertrophy].
Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
[TBL] [Abstract][Full Text] [Related]
3. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
Fourcade RO; Théret N; Taïeb C;
BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
[TBL] [Abstract][Full Text] [Related]
4. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.
Barkin J; Roehrborn CG; Siami P; Haillot O; Morrill B; Black L; Montorsi F;
BJU Int; 2009 Apr; 103(7):919-26. PubMed ID: 19239460
[TBL] [Abstract][Full Text] [Related]
5. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
Chalise PR; Agrawal CS
Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
[TBL] [Abstract][Full Text] [Related]
6. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.
Eckhardt MD; van Venrooij GE; van Melick HH; Boon TA
J Urol; 2001 Aug; 166(2):563-8. PubMed ID: 11458069
[TBL] [Abstract][Full Text] [Related]
8. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Becher E; Miñana B; Mirone V; Castro R; Wilson T; Montorsi F;
Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
10. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
[TBL] [Abstract][Full Text] [Related]
11. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of benign prostatic hyperplasia in general practice and practical approach of the Tunisian general practitioner (Prevapt study)].
Horchani A; Binous MY; Ben Hamida A; Sallami S; El Adbi H; Naji A
Tunis Med; 2007 Aug; 85(8):619-24. PubMed ID: 18254279
[TBL] [Abstract][Full Text] [Related]
13. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia.
Agrawal CS; Chalise PR; Bhandari BB
Nepal Med Coll J; 2008 Jun; 10(2):104-7. PubMed ID: 18828432
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
O'Leary MP; Wei JT; Roehrborn CG; Miner M;
BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
[TBL] [Abstract][Full Text] [Related]
15. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
Nickel JC; Elhilali M; Vallancien G;
BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
[TBL] [Abstract][Full Text] [Related]
17. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
18. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
[TBL] [Abstract][Full Text] [Related]
19. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
[TBL] [Abstract][Full Text] [Related]
20. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
Tsukamoto T; Masumori N; Rahman M; Crane MM
Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]